Tag results for 'Foreign Corrupt Practices Act'

Changes in the US DoJ’s corporate enforcement policy: implications for Indian companies

This article analyses possible implications of changes to the US Department of Justice’s enforcement policy for Indian companies.

Released on Apr 25, 2022

Disclosure of an Indian issuer’s potential FCPA violations: the implications for other Indian companies

Dr Reddy’s Laboratories Ltd (Dr Reddy’s), a large Indian pharmaceutical company, has American Depositary Receipts (ADRs) listed on the New York Stock Exchange and is an ‘issuer’ under the Foreign Corrupt Practices Act, 1977 (FCPA). In November 2020, Dr Reddy’s made a filing before the US Securities and Exchange Commission (SEC) stating that it had begun an investigation into an anonymous complaint alleging breaches of anti-corruption laws, specifically the FCPA.

Released on Oct 29, 2021